Health and Nutrition Survey on Shenzhen Children

May 21, 2022 updated by: Zhou Ji-Chang, Shenzhen Center for Chronic Disease Control

Investigation on Nutritional Health and Growth Status of Primary and Middle School Students in Shenzhen, 2021

  1. Master and analyze the nutritional health, growth and development status of primary and secondary school students in Shenzhen, and discover the main nutritional health, growth and development problems and influencing factors.
  2. Provide basic data and evidence-based basis for the municipal government and related departments to formulate child health policies and measures.

Study Overview

Study Type

Observational

Enrollment (Actual)

4500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Shenzhen, Guangdong, China, 518020
        • Shenzhen Center for Chronic Disease Control

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Primary and secondary school students in Shenzhen.

Description

Inclusion Criteria:

With signed consent to be a study subject.

Exclusion Criteria:

None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: 6 months
mmHg
6 months
Weight
Time Frame: 6 months
kg
6 months
Height
Time Frame: 6 months
cm
6 months
Vitamin concentrations in circulation
Time Frame: 8 months
measured by EIA, CLIA or LC-MS/MS, nmol/L
8 months
Mineral concentrations in circulation
Time Frame: 8 months
measured by ICP-MS, mass/volume
8 months
Glucose and lipid concentrations in circulation
Time Frame: 6 months
measured by biochemical analyzer, mmol/L
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jingfan Xiong, Director, Shenzhen Center for Chronic Disease Control

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2021

Primary Completion (Actual)

February 28, 2022

Study Completion (Actual)

March 31, 2022

Study Registration Dates

First Submitted

October 28, 2021

First Submitted That Met QC Criteria

February 8, 2022

First Posted (Actual)

February 17, 2022

Study Record Updates

Last Update Posted (Actual)

May 24, 2022

Last Update Submitted That Met QC Criteria

May 21, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth Disorders

3
Subscribe